Patents by Inventor Kota KUME

Kota KUME has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210052572
    Abstract: [Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquin oline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 5, 2020
    Publication date: February 25, 2021
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Kota KUME, Hisao YOSHIDA, Hirotaka ANDO, Yuta TANAKA
  • Patent number: 10918634
    Abstract: [Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: February 16, 2021
    Assignee: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Kota Kume, Hisao Yoshida, Hirotaka Ando, Yuta Tanaka
  • Publication number: 20190076421
    Abstract: [Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 13, 2018
    Publication date: March 14, 2019
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Kota KUME, Hisao YOSHIDA, Hirotaka ANDO, Yuta TANAKA
  • Publication number: 20180042918
    Abstract: [Problem] The present invention pertains to a safer and more effective respiratory infection treating agent. [Solution] A respiratory infection treating agent containing, as an active ingredient, 7-[(3S,4S)-3-{(cyclopropylamino)methyl}-4-fluoropyrrolidine-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 11, 2016
    Publication date: February 15, 2018
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Kota KUME, Hisao YOSHIDA, Hirotaka ANDO, Yuta TANAKA